Sort
48,018 grants matching “immunotherapy”
Retinal Remodeling
$369,812Bryan William Jones · University Of Utah · R01 · FY2021 · EY
COMBINING NANOTECHNOLOGY AND RADIATION TO ENHANCE CHECKPOINT BLOCKADE IMMUNOTHERAPY OF ADVANCED PROSTATE CANCER
$369,806University Of Chicago · · FY2018 · Department of the Army
Biobehavioral Role of Brain Kynurenine Metabolism in Mental Illness
$369,806Jason C O'Connor · University Of Texas Hlth Science Center · R01 · FY2012 · MH
Role of T-bet, TIM Molecules, and Mucosal Adjuvants in the Induction of Oral Tole
$369,793Howard L Weiner · Brigham And Women'S Hospital · P01 · FY2007 · NS
Molecular Analysis of CD8, MHC Class I Interaction
$369,782Paula B. Kavathas · Yale University · R01 · FY2008 · CA
Project 2: Functions of ARID1A in muscle invasive bladder cancer
$369,765Cory Abate-Shen · Columbia University Health Sciences · P01 · FY2020 · CA
Project 2: Functions of ARID1A in muscle invasive bladder cancer
$369,765Cory Abate-Shen · Columbia University Health Sciences · P01 · FY2021 · CA
Project 2: Functions of ARID1A in muscle invasive bladder cancer
$369,765Cory Abate-Shen · Columbia University Health Sciences · P01 · FY2018 · CA
Targeted Nanomedicines with Synergistic Chemotherapeutics to Enhance Immunotherapy of Metastatic Colorectal Cancer
$369,756Wenbin Lin · University Of Chicago · R01 · FY2020 · CA
Targeted Nanomedicines with Synergistic Chemotherapeutics to Enhance Immunotherapy of Metastatic Colorectal Cancer
$369,756Wenbin Lin · University Of Chicago · R01 · FY2018 · CA
Targeted Nanomedicines with Synergistic Chemotherapeutics to Enhance Immunotherapy of Metastatic Colorectal Cancer
$369,756Wenbin Lin · University Of Chicago · R01 · FY2021 · CA
Preclinical Pharmacogenomics and Synaptic Biomarkers for Alzheimer's Disease
$369,716Gregory M Cole · University Of California Los Angeles · R01 · FY2014 · AT
Preclinical Pharmacogenomics and Synaptic Biomarkers for Alzheimer's Disease
$369,716Gregory M Cole · University Of California Los Angeles · R01 · FY2013 · AT
Preclinical Pharmacogenomics and Synaptic Biomarkers for Alzheimer's Disease
$369,715Gregory M Cole · University Of California Los Angeles · R01 · FY2015 · AT
Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease
$369,688Thomas M Wisniewski · New York University School Of Medicine · R01 · FY2010 · NS
Epitope-Specific Targeting of Tau Aggregates.
$369,688Einar M Sigurdsson · New York University School Of Medicine · R01 · FY2012 · NS
Epitope-Specific Targeting of Tau Aggregates.
$369,688Einar M Sigurdsson · New York University School Of Medicine · R01 · FY2011 · NS
Project 1: Evaluating the synergy of LAG3 and PD-1 in melanoma patients
$369,676Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P50 · FY2023 · CA
Project 2: Immunotherapy with CMP-001 intratumoral and nivolumab in melanoma
$369,675Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2023 · CA
Project 3: Localized microneedle-directed combination immunotherapy for cSCC
$369,675Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2023 · CA
Allosteric therapy of the Clostridium difficile toxins
$369,655Tor C. Savidge · Baylor College Of Medicine · R01 · FY2013 · AI
Synthetic IL9R signaling to rewire T cells for adoptive cell therapy of cancer
$369,646Anusha Kalbasi · Stanford University · R37 · FY2022 · CA
A Novel Anti-HER2/neu IgE for Breast Cancer Therapy
$369,640Manuel L Penichet · University Of California Los Angeles · R01 · FY2014 · CA
Development
$369,602Ramanuj Dasgupta · New York University School Of Medicine · P30 · FY2011 · CA
Tissue Factor and Emdometriosis
$369,563Charles Lockwood · Yale University · U54 · FY2009 · HD